Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	108.10	108.46	52.12
Graham Fair Price	92.19	35.17	18.30
PEG	-99.38	< 0.005	0.83
Price/Book	9.39	3.32	3.03
Price/Cash Flow	4492.16	-860.89	18.75
Prices/Earnings	-79.88	-2.81	13.97
Price/Sales	5.53	4.34	4.11
Price/FCF	4492.16	-860.89	18.75
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	-10.35	0.58	0.65
Operating Margin	-70.35	0.03	0.09
ROA	411.89	-0.07	0.01
ROE	0.05	-0.30	443.70
ROIC	0.02	< 0.005	-61.74
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	-0.04	-0.02	-73.66
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.22	-0.75	239.05
EPS QOQ	0.17	-5.48	3144.53
FCF QOQ	2.77	-1.02	-63.17
Revenue QOQ	0.11	-0.14	35.70
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	183.97	152.12	-17.31
Days Sales Outstanding (DSO)	23.40	28.11	20.14
Inventory Turnover	0.49	0.59	20.94
Debt/Capitalization	0.66	0.57	-13.23
Quick Ratio	0.34	0.35	1.38
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	16.56	13.65	-17.58
Cash	2.13	1.75	-17.92
Capex	-0.42	-0.43	-1.42
Free Cash Flow	2.68	-0.05	-98.04
Revenue	12.22	10.44	-14.56
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	1.06	0.95	-10.23
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	19.34	42.13	117.80
Naive Interpretation	Member

06 - Financial Health · Bad

Rating